https://www.pharmaglobenewswire.com/inflammatory-myositis-market-set-for-remarkable-growth-projected-cagr-of-11-7-through-2034-driven-by-emerging-therapies-and-rising-patient-demand-across-seven-major-markets/Pharma Globenewswireen2026-04-16T06:50:25+01:00Inflammatory Myositis Market Set for Remarkable Growth: Projected CAGR of 11.7% Through 2034 Driven by Emerging Therapies and Rising Patient Demand Across Seven Major Markets https://www.pharmaglobenewswire.com/chronic-spontaneous-urticaria-market-set-to-surpass-usd-2000-million-by-2025-driven-by-emerging-biologics-rising-disease-awareness-and-expanding-global-treatment-access/Pharma Globenewswireen2026-04-16T06:49:24+01:00Chronic Spontaneous Urticaria Market Set to Surpass USD 2000 Million by 2025, Driven by Emerging Biologics, Rising Disease Awareness, and Expanding Global Treatment Access https://www.pharmaglobenewswire.com/whim-syndrome-market-epidemiology-insights-emerging-therapies-pipeline-analysis-and-growth-forecast-across-the-7-major-markets-through-2034/Pharma Globenewswireen2026-04-14T13:22:06+01:00WHIM Syndrome Market: Epidemiology Insights, Emerging Therapies, Pipeline Analysis, and Growth Forecast Across the 7 Major Markets Through 2034